Summit Global Investments »

Castle Biosciences shares owned by Summit Global Investments

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $518k 24k 21.75

More positions owned by Summit Global Investments

Rbb Fd Inc S Gi Enhanced Cor (USDX)
Rbb Fd Inc S Gi Us Large Cap (SGLC)
Rbb Fd Inc S Gi Enhanced Glb (GINX)
Rbb Fd Inc S Gi Diversi Tac (DYTA)
Ishares Tr C Ore Us Aggbd Et (AGG)
Nvidia Corporation C Om (NVDA)
Microsoft Corp C Om (MSFT)
Meta Platforms Inc C L A (META)
Alphabet Inc C Ap Stk Cl A (GOOGL)
Invesco Qqq Tr U Nit Ser 1 (QQQ)
Progressive Corp C Om (PGR)
Amazon Com Inc C Om (AMZN)
Apple Inc C Om (AAPL)
Merck & Co Inc C Om (MRK)
United Therapeutics Corp Del C Om (UTHR)

View all positions for Summit Global Investments

Top funds holding Castle Biosciences

BlackRock
Daniel D. Thurber
Granahan Investment Management
Vanguard Group
Principal Financial Group
Bellevue Group
Portolan Capital Management
Deerfield Management Company
Soleus Capital Management
Dimensional Fund Advisors
Citadel Advisors
State Street Corporation
Geode Capital Management
Kornitzer Capital Management
Palisade Capital Management

View all funds holding Castle Biosciences